Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This project proposes a structuring of supportive oncology care for the recovery phase after gynecological cancer (ovarian/trope/peritoneum or endometrium). Patients will be divided into three groups based on the identification of oncological support care needs. Patients with supportive oncology care needs will be randomized into two groups: the experimental group, receiving a personalized post-cancer plan with a multidisciplinary assessment of supportive oncology care needs in a day hospital and coordinated follow-up by the referring study nurse, and the control group, receiving a personalized post-cancer plan without a day hospital. Randomization will be stratified according to tumor location (ovary vs. endometrium), use of supportive oncology care during treatment, and treatment center. Patients with no need for supportive oncology care will be followed in an observational cohort. The main objective is to identify and manage the supportive oncology care needs of patients in remission from endometrial or ovarian cancer to improve their quality of life and post-treatment follow-up. A medico-economic analysis will be performed.

Who May Be Eligible (Plain English)

Who May Qualify: - Patient \> 18 years - Patients in remission from first-line treatment of endometrial or ovarian/tumor/peritoneal cancer. - Patient who has completed her initial treatment; patients on maintenance therapy are eligible. - Fluency in French - Patient with access to a telephone line - Patient affiliated to a social security scheme - Signature of willing to sign a consent form prior to any specific study procedure Who Should NOT Join This Trial: - Any associated medical or psychiatric condition that could compromise the patient's ability to participate in the study - Patient with locoregional or metastatic recurrence - Patient deprived of liberty, under guardianship or curatorship - Simultaneous participation in a therapeutic clinical trial Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Patient \> 18 years * Patients in remission from first-line treatment of endometrial or ovarian/tumor/peritoneal cancer. * Patient who has completed her initial treatment; patients on maintenance therapy are eligible. * Fluency in French * Patient with access to a telephone line * Patient affiliated to a social security scheme * Signature of informed consent prior to any specific study procedure Exclusion Criteria: * Any associated medical or psychiatric condition that could compromise the patient's ability to participate in the study * Patient with locoregional or metastatic recurrence * Patient deprived of liberty, under guardianship or curatorship * Simultaneous participation in a therapeutic clinical trial

Treatments Being Tested

OTHER

Multidisciplinary assessment

Delivery of a personalized post-cancer plan with multidisciplinary assessment of oncology support care needs in a day hospital

OTHER

Standard assesment

Delivery of a personalized post-cancer plan without a day hospital

OTHER

Observational cohort

Patients with no cancer sequelae, no adverse effects and no need for oncological support care will not be randomized, but will be followed as part of an observational cohort

Locations (13)

CHU, Besançon
Besançon, France
François Baclesse
Caen, France
Centre Jean Perrin
Clermont-Ferrand, France
Centre Léon Bérard
Lyon, France
Hopital Diaconesses Croix Saint-Simon
Paris, France
Hopital Europeen George Pompidou
Paris, France
Hôpital COCHIN
Paris, France
Institut Curie
Paris, France
Hopital privé des Côtes d'Armor
Plérin, France
Institut Curie, St Cloud
Saint-Cloud, France
CHU, Saint Etienne
Saint-Etienne, France
CHU
Strasbourg, France
Gustave Roussy
Villejuif, France